By 
A Biden administration plan to lower prescription drug prices offers the first detailed road map of administrative actions the White House would support in addition to legislation aimed at driving down costs.
The plan, to be released Thursday, backs legislation from congressional Democrats, including a push to empower the federal government to negotiate for drug prices in Medicare and pass those lower costs along to the private sector. The road map goes further, however, by outlining administrative actions by agencies and departments that could come in concert with possible legislative changes.
Administrative measures include testing reimbursement for drugs in Medicare based on the clinical value they provide to patients and offering federal funding for research into new treatments, according to the plan viewed by The Wall Street Journal.
Medicare is the health program for people aged 65 and older and younger people with disabilities.
An expanded version of this story appears on WSJ.com
Popular stories from WSJ.com:
Comments